kongre.net
Welcome to kongre.net

Speaker

Anita Bellail

Chief Executive Officer, HB Therapeutics, Inc.

Anita Bellail, Chief Executive Officer at HB Therapeutics, Inc., spoke at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Molecular Glue Degrader–Induced Co-Degradation of Mutant KRAS & CRAF Drives In Vivo Responses”.

Conferences
1
Keynotes
0
Upcoming
0

Past appearances

More speakers at 9th TPD & Induced Proximity Summit

  • Stuart Schreiber

    Professor, Harvard Medical School

  • Randy Teel

    President & Chief Executive Officer, Arvinas, Inc.

  • Carla Bauer

    Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

  • Alyn Davies

    Associate Director, Medicinal Chemistry, AstraZeneca

  • Adam Gilbert

    Science Partner, Flagship Pioneering

  • Jason Kantor

    Chief Business Officer, Nurix Therapeutics, Inc.

See all 61 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Anita Bellail, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].